GAITHERSBURG, Maryland (Reuters) A new, longer-lasting emergency contraceptive pill moved closer to the U.S market on Thursday after U.S medical advisers unanimously backed the one-dose drug as a safe and effective option to prevent an unplanned pregnancy.Data for the drug, made by the French drugmaker HRA Pharma but to be sold by Watson Pharmaceuticals Inc in the United States, was compelling